Telehealth General Psychiatry Prescribing: What Prescribers Can Do in Pennsylvania

If you’re a psychiatrist or psychiatric nurse practitioner wondering what you can actually prescribe via telehealth—especially controlled substances like Adderall, Xanax, or Suboxone—you’re not alone. The rules have been a moving target since 2020, and they vary wildly by state and provider type.

Here’s the reality: As of early 2026, psychiatrists can prescribe nearly all psychiatric medications through telehealth, including Schedule II stimulants and benzodiazepines, thanks to extended federal waivers. But the details matter—especially if you’re a PMHNP navigating scope-of-practice laws, or if you’re practicing across multiple states.

This guide cuts through the confusion. We’ll cover what psychiatrists and PMHNPs can prescribe via telehealth, how state laws differ (particularly in California, Texas, Florida, New York, Pennsylvania, and Illinois), the gap between MD and NP prescribing authority, and what you actually get paid for medication management visits.

The Federal Baseline: DEA Waivers and Controlled Substance Prescribing

Let’s start with the big one: controlled substances via telehealth.

Historically, the Ryan Haight Act required an in-person medical evaluation before a provider could prescribe Schedule II–V controlled substances. That created a massive bottleneck for telepsychiatry, especially for ADHD (stimulants) and anxiety (benzodiazepines) treatment.

Since March 2020, the DEA has waived this requirement under public health emergency powers. That waiver has been extended multiple times and remains in effect through December 31, 2025 (National Law Review, Aug 2025). As of February 2026, it’s still active—meaning psychiatrists nationwide can initiate controlled substance prescriptions via video visit without ever seeing the patient in person.

This has been a game-changer for ADHD management, buprenorphine for opioid use disorder, and benzodiazepines for anxiety—all of which can now be prescribed remotely if clinically appropriate.

What’s coming: The DEA has proposed permanent rules that would reinstate some in-person requirements, possibly with exceptions for initial 30-day prescriptions or if a patient was referred by an in-person clinician (Nixon Peabody, June 2025). Those rules aren’t finalized yet. Until they are, psychiatrists should assume the current flexibility continues—but stay alert for DEA announcements in late 2024 or early 2025.

Bottom line for psychiatrists: You can prescribe controlled substances via telehealth right now. Just ensure you’re conducting a legitimate video evaluation that meets the standard of care, documenting appropriately, and checking your state’s Prescription Monitoring Program (PMP) before prescribing.

Free consultations available with select providers only.

Grow your practice on Klarity

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Start seeing patients

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

State-Specific Rules: Where Telehealth Prescribing Gets Complicated

While federal law sets the floor, state laws add layers—especially around what counts as a valid telemedicine encounter, whether certain drug classes are restricted, and (critically) whether psychiatric nurse practitioners need physician supervision.

Here’s how the key states stack up:

Texas: Telehealth-Friendly for Psychiatry, But NPs Are Restricted

Texas allows telemedicine prescribing if the standard of care is met and the encounter is conducted via real-time audio-visual technology (CCHP Texas Summary, Jan 2026).

For psychiatrists: You can prescribe psychiatric medications, including controlled substances, via telehealth. The one major exception: Texas prohibits tele-prescribing Schedule II opioids for chronic pain management—you’d need an in-person visit for that (CCHP Texas). But prescribing stimulants for ADHD or benzodiazepines for anxiety via telehealth? Totally allowed under state law.

For PMHNPs: Texas is a restricted practice state—you cannot prescribe anything independently. You must have a written Prescriptive Authority Agreement with a Texas-licensed physician (Texas Board of Nursing FAQ). Worse, Texas law generally prohibits NPs from prescribing Schedule II controlled substances in outpatient settings, except in very narrow circumstances (terminal illness, emergencies) (CCHP Texas). In practice, many Texas PMHNPs have the collaborating psychiatrist write initial stimulant prescriptions, then the NP manages refills under Schedule III–V drugs or non-controlled alternatives.

Texas also caps physician supervision at 7 NPs/PAs per physician and requires monthly meetings during the first 3 years of collaboration (Texas Legislature SB 406, 2013).

Workforce reality: Texas has one of the worst psychiatrist shortages in the nation (1 psychiatrist per ~9,000 residents, with 614 psychiatrists needed to fill Health Professional Shortage Areas) (Healing Psychiatry Florida, Jan 2026). Telehealth is essential to bridging this gap—but NPs face significant barriers compared to MDs.

Florida: Explicitly Permits Teleprescribing for Psychiatric Treatment

Florida has one of the more permissive telehealth laws for psychiatry. State law explicitly allows controlled substances to be prescribed via telehealth for the treatment of psychiatric disorders (Florida Statutes 456.47) (Florida Statute 464.012).

For psychiatrists: You can initiate ADHD stimulants, anti-anxiety medications, or any other psychiatric controlled substance via video visit. The only prohibition is for chronic non-malignant pain management—that still requires in-person evaluation. For mental health? You’re clear.

For PMHNPs: Florida is complicated. The state passed legislation in 2020 (HB 607) allowing ‘autonomous practice’ for some nurse practitioners—but psychiatric NPs were excluded (NP Schools Florida Guide). Only family, pediatric, and internal medicine NPs can practice independently. PMHNPs still require a supervising physician.

However, Florida has a carve-out: If you’re a ‘psychiatric nurse’ (defined as a PMHNP with 2+ years of post-grad experience under a psychiatrist), you can prescribe psychotropic controlled substances for mental health treatment in collaboration with a psychiatrist—and you’re exempt from the 7-day Schedule II prescription limit that applies to other NPs (Florida Statute 464.012). This means a Florida PMHNP can manage long-term ADHD stimulant therapy, but they still need a collaborating psychiatrist on paper.

Bills to extend autonomous practice to psychiatric NPs have been introduced (e.g., HB 771 in 2024) but haven’t passed (Florida Senate Bill 771/2024).

New York: NPs Gain Independence After 2 Years; State Aligned with Federal Telehealth Rules

New York recently updated its rules to align state and federal controlled substance prescribing via telehealth.

For psychiatrists: You can prescribe controlled substances via telehealth under the federal DEA waiver. In mid-2025, New York finalized regulations explicitly permitting this, removing state-level barriers (Nixon Peabody Alert, June 2025). New York does require checking the state’s Prescription Monitoring Program (I-STOP registry) before prescribing Schedule II–IV drugs, and all controlled substance prescriptions must be e-prescribed.

For PMHNPs: New York has a reduced practice to full practice authority pathway. New NPs must start with a written collaborative agreement with a physician for their first 3,600 hours of practice (roughly 2 years full-time). After that, they can practice independently—no written agreement or chart review required (JD Supra, April 2022). They must attest to having a ‘collaborative relationship’ with physicians (informal consultative ties), but there’s no ongoing supervision.

In effect, experienced New York PMHNPs have full prescribing authority, including controlled substances, and operate nearly identically to psychiatrists in terms of scope.

California: Transitioning to Full NP Independence by 2026

California is in the middle of a major transition thanks to AB 890 (2020), which created a pathway for nurse practitioners to practice independently.

For psychiatrists: Full independent prescribing. California permits telehealth prescribing after a ‘good faith exam,’ and a video evaluation qualifies (National Law Review, Aug 2025). You must check CURES (California’s PMP) before prescribing Schedule II–IV drugs.

For PMHNPs: As of January 2023, California NPs with ≥3 years of experience can become ‘103 NPs’ and practice without physician supervision in collaborative settings like clinics or group practices (CA Board of RN, AB 890). Starting January 1, 2026, those NPs can apply to become ‘104 NPs’ and practice fully independently, even solo (CA BRN).

By 2026, California will effectively be a full practice authority state for experienced NPs. New grads will still need to work under physician-supervised standardized procedures for at least 3 years, but after that, they’re on equal footing with psychiatrists in terms of prescribing authority.

Pennsylvania: NPs Still Require Collaboration; No FPA Yet

Pennsylvania currently requires nurse practitioners to maintain a collaborative agreement with a physician indefinitely—there’s no pathway to independent practice yet (PA Coalition of NPs).

For psychiatrists: Full independent prescribing. No unique telehealth restrictions beyond federal law.

For PMHNPs: You must have a collaborative agreement filed with the PA Board of Nursing. The agreement must detail which drugs you can prescribe. PA law allows NPs to prescribe Schedule II–V controlled substances if the collaborating physician delegates it and it’s within the NP’s specialty (PA CNP).

There’s an additional restriction: NP-prescribed Schedule II drugs are limited to a 30-day supply for initial prescriptions, and the physician must be notified within 24 hours. The physician must also countersign a certain percentage of the NP’s charts (often 100% for Schedule II prescriptions).

Legislation to grant full practice authority (SB 25) passed the PA Senate in 2021 but stalled in the House. It may resurface, but as of 2026, PMHNPs in Pennsylvania operate under physician oversight.

Illinois: NPs Can Earn Full Practice Authority After Transition Period

Illinois has a reduced practice to FPA pathway similar to New York’s, but with different requirements.

For psychiatrists: Full independent prescribing. Illinois has strong telehealth parity laws requiring private insurers to reimburse telehealth at the same rate as in-person through at least 2027.

For PMHNPs: You must complete 4,000 hours of clinical practice under a written collaborative agreement (roughly 2 years full-time) plus 250 hours of continuing education in advanced pharmacology (NursePractitionerLicense.com, Feb 2024). After meeting these requirements, you can apply for an Illinois Full Practice Authority APRN license and prescribe independently, including controlled substances.

Until you have FPA, your prescriptions must be under physician delegation—the physician’s name must appear on scripts as the delegating practitioner. Once you have FPA, you operate independently and can obtain your own mid-level controlled substance registration.

Illinois also uniquely allows licensed clinical psychologists with specialized training to prescribe a limited formulary of mental health medications under a psychiatrist’s supervision—a creative solution to prescriber shortages.

PMHNP vs Psychiatrist Prescribing Authority: The Real Gap

The scope-of-practice divide between PMHNPs and psychiatrists creates real operational complexity for telehealth platforms and practices:

Psychiatrists (MD/DO):

• Unrestricted prescribing authority in all 50 states
• No collaborative agreements or supervision required
• Full DEA registration for Schedule II–V controlled substances
• Can practice and prescribe independently from day one of licensure

Psychiatric Nurse Practitioners (PMHNPs):

• Authority varies dramatically by state
• About 34 states grant Full Practice Authority (as of 2025), allowing independent prescribing after meeting requirements (NursePractitionerOnline, Feb 2026)
• States like Texas, Florida (for psych), and Pennsylvania still require ongoing physician collaboration
• Some states (NY, IL, CA) require initial supervised practice hours before granting independence
• Reimbursement often differs: Medicare pays NPs at 85% of physician rates when billing under the NP’s own NPI (NursePractitionerOnline)

What this means for practice:

If you’re a telepsychiatry platform operating across multiple states, you need a different practice model for each state:

• In full practice authority states (e.g., Washington, Arizona, New York after 3,600 hours), PMHNPs can see patients and prescribe independently
• In restricted states (Texas, Florida), you need collaborating psychiatrists on staff to supervise NPs—which adds cost and complexity
• In transition states (NY, IL, CA), you need to track each NP’s hours and credentials to know when they can practice independently

This isn’t just regulatory minutiae—it affects patient access, provider autonomy, and practice economics.

Collaborative Practice Agreements: What They Actually Require

In states where PMHNPs need physician collaboration, the requirements vary widely:

Common CPA elements:

• Scope definition: Which medications the NP can prescribe, patient populations they can treat
• Availability requirements: Physician must be reachable for consultation (often within a specified timeframe)
• Chart review: Many states require the physician to review a percentage of the NP’s charts (e.g., 10% monthly in South Carolina, 100% of Schedule II prescriptions in Pennsylvania)
• Meeting frequency: Some states mandate regular face-to-face meetings (Texas requires monthly meetings for the first 3 years, then quarterly) (Texas Legislature SB 406)
• Ratio limits: Texas caps one physician to supervising 7 NPs/PAs total (Texas Legislature)
• Specialty matching: Some states (Florida, Pennsylvania) require the collaborating physician to be in the same specialty—meaning a PMHNP needs a psychiatrist collaborator for psychiatric prescribing

The practical pain points:

Many PMHNPs report that finding a collaborating psychiatrist is the biggest barrier to practice in restricted states—especially in underserved areas where psychiatrists are scarce. Some physicians charge $1,000–$3,000/month to serve as a collaborator, which cuts into the NP’s income. For telehealth platforms, this means either employing psychiatrists to supervise NPs (adding overhead) or limiting NP hiring to full practice authority states.

Reimbursement for Psychiatric Medication Management: What You Actually Get Paid

Let’s talk money. Understanding reimbursement is crucial for evaluating whether telehealth psychiatry is financially viable—and for comparing employment models (traditional practice vs. platforms like Klarity).

Common billing codes for medication management:

• 90792 – Initial psychiatric evaluation with medical services (60 min): ~$173 Medicare 2026 (TheraThink, 2026)
• 99213 – Established patient office visit, 15 min med check: ~$95 Medicare 2026 (TheraThink)
• 99214 – Established patient, 25 min or moderate complexity: ~$136 Medicare 2026 (TheraThink)

Private insurance typically pays 1.2–2x Medicare rates in most markets (e.g., $150–$200 for a 99214).

Telehealth parity: Most states now require insurers to reimburse telehealth at the same rate as in-person for behavioral health. States with strong parity laws include Illinois (mandated through 2027), California, New York, and Florida (voluntary but widely adopted) (National Law Review).

NP reimbursement: Medicare pays NPs at 85% of physician rates when billed under the NP’s NPI (NursePractitionerOnline). Some private payers follow this, others pay equal rates. A few states (Nevada, Maryland) have mandated equal reimbursement by law.

What this means for a typical med management practice:

Let’s say you’re a psychiatrist doing primarily 15-minute follow-ups (99213) with occasional 25-minute visits (99214):

• Medicare patients: $95 for brief follow-ups, $136 for longer visits
• Commercial insurance: $120–$200 for brief follow-ups, $170–$250 for longer visits
• If you see 4 patients/hour: That’s roughly $480–$800/hour gross revenue (before overhead)

For PMHNPs, reduce those figures by ~15% for Medicare and some commercial plans.

Compare this to traditional employment: Many psychiatrists in outpatient settings earn $200–$300/hour as employees. If you’re generating $500–$800/hour in collections but only taking home $250, the difference is overhead (rent, billing, malpractice, admin staff).

Telehealth platforms remove that overhead: No office lease, no billing department, no front desk. The trade-off is you’re paid per appointment rather than per hour of availability. We’ll come back to this when comparing practice models.

The Economics of Patient Acquisition: Why DIY Marketing Rarely Pencils Out

Here’s where most psychiatrists get stuck when building a telehealth practice: patient acquisition is expensive and slow.

The real cost of acquiring a qualified psychiatric patient:

Let’s be honest about the numbers. When psychiatrists try to build a patient panel through DIY marketing, the all-in cost per booked patient is typically $200–$500+ once you factor in:

• SEO investment: Takes 6–12 months of consistent content creation, technical optimization, and link building before you see meaningful traffic. Most solo providers don’t have the expertise or patience. If you hire an agency, expect $2,000–$5,000/month with no guarantee of results in the first year.

• Google Ads: Mental health keywords are expensive. ‘Psychiatrist near me’ costs $15–$40+ per click in major markets. A realistic conversion rate from click to booked appointment is 5–10%, meaning you’re spending $150–$400+ per booked patient. And that’s assuming you’ve optimized your landing page and booking flow—which most providers haven’t.

• Directory listings: Psychology Today charges $29.95/month for a basic listing, but you’re competing with hundreds of other providers on the same results page. Zocdoc charges $35–$100+ per booking, plus monthly subscription fees. The math adds up fast.

• Staff time: Someone needs to answer inquiries, qualify leads, handle no-shows from cold traffic (which can be 30–40% for first appointments from ads), and manage follow-up. Even part-time admin adds $1,500–$3,000/month to your overhead.

• Failed campaigns: Most providers test 3–5 different channels before finding one that works consistently. That trial-and-error burns through thousands in ad spend with minimal return.

The honest assessment: If you have $5,000–$10,000/month to invest in marketing for 6–12 months with uncertain ROI, and you’re willing to learn (or hire) SEO/PPC expertise, DIY marketing can eventually work.

But for most providers—especially those starting out or scaling quickly—it’s a gamble with your time and money.

The alternative: Pay-per-appointment models

Platforms like Klarity Health use a different approach: you only pay when a qualified patient actually books with you. There’s typically a standard listing fee per new patient lead (similar to Zocdoc’s per-booking model), but:

• No upfront marketing spend or monthly subscriptions while you wait for results
• Pre-qualified patients already matched to your specialty and availability
• No wasted ad spend on clicks that don’t convert
• Built-in telehealth infrastructure (no separate platform costs)
• Both insurance and cash-pay patient flow handled through one system
• You control your schedule—only pay when you see patients

The ROI comparison:

Instead of spending $3,000–$5,000/month on marketing with uncertain results, you pay a listing fee only when a patient books. For a new patient who becomes a long-term medication management case (say, 12 follow-ups at $150 each = $1,800 lifetime value), that’s guaranteed positive ROI from appointment one.

This is why experienced psychiatrists increasingly view patient acquisition platforms not as ‘giving up revenue’ but as trading upfront risk for guaranteed patient flow.

State-by-State Summary: Prescribing Rules, NP Authority, and Telehealth Notes

Practical Takeaways for Psychiatrists and PMHNPs

If you’re a psychiatrist:

1. You can prescribe nearly everything via telehealth right now, including Schedule II stimulants and benzodiazepines, under current federal waivers. Just ensure you’re conducting a proper video evaluation and checking your state’s PMP.

2. State rules matter for some edge cases: Don’t prescribe Schedule II opioids for chronic pain via telehealth in Texas. Know your state’s e-prescribing and PMP requirements.

3. Reimbursement is solid: Medicare pays ~$95 for 15-minute med checks, $136 for 25-minute visits, with private insurance typically paying 1.5–2x those amounts. Telehealth parity laws ensure you’re paid the same as in-person in most states.

4. Patient acquisition is the real bottleneck: Building a panel through DIY marketing costs $200–$500+ per patient and takes 6–12 months. Pay-per-appointment platforms remove that risk and upfront cost.

If you’re a PMHNP:

1. Your authority depends entirely on your state: In FPA states (or after meeting transition requirements in NY/IL/CA), you practice like a psychiatrist. In restricted states (TX, FL, PA), you need a collaborating physician and face prescribing limits.

2. Controlled substance prescribing varies: Even in states where you can prescribe Schedule II drugs, some (like Texas) restrict it heavily. Know your state’s rules and your collaborative agreement’s terms.

3. Finding a collaborator is often the biggest barrier in restricted states. Platforms that provide collaborating physicians remove this obstacle.

4. Reimbursement is slightly lower: Expect 85% of physician rates for Medicare, and slightly less from some private payers. This is a consideration when evaluating income potential.

For both:

The regulatory landscape is moving toward more telehealth flexibility and more NP independence—but the pace varies wildly by state. Stay current with your state board’s rules, check the DEA’s website for updates on controlled substance prescribing, and consider practice models that remove the administrative burden of compliance.

Why Klarity Health Makes Sense for Psychiatric Prescribers

Here’s the business case in plain terms:

Traditional practice model:

• Spend $3,000–$5,000/month on marketing
• Wait 6–12 months for SEO to generate consistent leads
• Handle billing, credentialing, EHR, admin staff
• Take on all the risk of failed marketing campaigns
• Gross revenue of $500–$800/hour, net income of $200–$300/hour after overhead

Klarity Health model:

• No upfront marketing spend: Pay a listing fee per new patient booked
• Pre-qualified patient flow: Patients already matched to your specialty and availability
• No overhead: No billing staff, no office lease, no EHR subscription
• **Built-in tele

Source:

• https://www.bon.texas.gov/faqpracticeaprn.asp.html#:~:text=certificate%20or%20fetal%20death%20certificate,For%20additional%20information
• https://www.npschools.com/blog/guide-to-np-practice-in-florida#:~:text=match%20at%20L200%20%E2%80%9CUnder%20HB,%E2%80%9D
• https://natlawreview.com/article/telehealth-and-person-visits-tracking-federal-and-state-updates-pandemic-era#:~:text=In%20late%202024%2C%20the%20U,prescribing
• https://www.flsenate.gov/laws/statutes/2024/464.012#:~:text=,the%20treatment%20of%20mental%20disorders
• https://www.cchpca.org/texas/#:~:text=including%2C%20but%20not%20limited%20to%2C,Code%2C%20Chapters%20481%20and%20483
• https://www.cchpca.org/texas/#:~:text=,way%20communication
• https://www.nursepractitioneronline.com/articles/nurse-practitioner-practice-authority-updates/#:~:text=As%20of%202025%2C%20the%20distribution,toward%20greater%20autonomy%20for%20NPs
• https://www.nursepractitioneronline.com/articles/nurse-practitioner-practice-authority-updates/#:~:text=,Michigan%20%282025
• https://www.pacnp.org/general/custom.asp?page=ScopeofPractice#:~:text=tests%2C%20and%20deliver%20other%20health,appropriate%20experience%20can%20receive%20a
• https://www.jdsupra.com/legalnews/new-law-allows-experienced-nps-to-8292796/#:~:text=New%20York%E2%80%99s%202023%20state%20budget%2C,practice%20without%20a%20collaborative%20relationship